The proportion with incident delayed filling at @ year was similar among eyes treated with ranibizumab ( @ -LSB- @ % -RSB- of @ ) or bevacizumab ( @ -LSB- @ % -RSB- of @ ; P = @ ) and among eyes treated monthly ( @ -LSB- @ % -RSB- of @ ) or as needed ( @ -LSB- @ % -RSB- of @ ; P = @ ) .